CG
Clarus Group’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,757
| Closed | -$206K | – | 105 |
|
|
2024
Q4 | $206K | Sell |
7,757
-473
| -6% | -$12.5K | 0.07% | 100 |
|
|
2024
Q3 | $238K | Sell |
8,230
-84
| -1% | -$2.43K | 0.1% | 98 |
|
|
2024
Q2 | $233K | Sell |
8,314
-10,274
| -55% | -$287K | 0.1% | 104 |
|
|
2024
Q1 | $516K | Buy |
18,588
+426
| +2% | +$11.8K | 0.36% | 48 |
|
|
2023
Q4 | $523K | Sell |
18,162
-78
| -0.4% | -$2.25K | 0.4% | 47 |
|
|
2023
Q3 | $605K | Sell |
18,240
-526
| -3% | -$17.4K | 0.44% | 43 |
|
|
2023
Q2 | $688K | Buy |
18,766
+1,641
| +10% | +$60.2K | 0.5% | 32 |
|
|
2023
Q1 | $699K | Buy |
17,125
+15
| +0.1% | +$612 | 0.66% | 25 |
|
|
2022
Q4 | $877K | Buy |
17,110
+12
| +0.1% | +$615 | 0.77% | 23 |
|
|
2022
Q3 | $748K | Sell |
17,098
-287
| -2% | -$12.6K | 0.68% | 30 |
|
|
2022
Q2 | $911K | Sell |
17,385
-288
| -2% | -$15.1K | 0.76% | 24 |
|
|
2022
Q1 | $915K | Sell |
17,673
-5,580
| -24% | -$289K | 0.62% | 26 |
|
|
2021
Q4 | $1.25M | Hold |
23,253
| – | – | 0.84% | 21 |
|
|
2021
Q3 | $1M | Buy |
23,253
+13
| +0.1% | +$559 | 0.69% | 25 |
|
|
2021
Q2 | $921K | Sell |
23,240
-1,190
| -5% | -$47.2K | 0.69% | 25 |
|
|
2021
Q1 | $877K | Buy |
24,430
+17
| +0.1% | +$610 | 0.73% | 25 |
|
|
2020
Q4 | $848K | Buy |
+24,413
| New | +$848K | 0.73% | 22 |
|